Co-Authors
This is a "connection" page, showing publications co-authored by Ming-Hua Zheng and Hua-Dong Yan.
Connection Strength
1.115
-
Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Front Endocrinol (Lausanne). 2021; 12:604100.
Score: 0.233
-
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients. J Gastroenterol Hepatol. 2021 Jan; 36(1):204-207.
Score: 0.221
-
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. Gut. 2020 08; 69(8):1545-1547.
Score: 0.221
-
Fatal outcome in a liver transplant recipient with COVID-19. Am J Transplant. 2020 07; 20(7):1907-1910.
Score: 0.220
-
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis. J Hepatol. 2020 09; 73(3):719-721.
Score: 0.220